As you will be aware The Department for Health & Social Care has asked NICE to conduct an appraisal of Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]
Please note that following on from a request received from the company this appraisal have been scheduled into the work programme and the appraisal is now anticipated to begin during early July 2025 when we will write to you about how you can get involved.